0001485003-18-000003.txt : 20180122 0001485003-18-000003.hdr.sgml : 20180122 20180122161242 ACCESSION NUMBER: 0001485003-18-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180118 FILED AS OF DATE: 20180122 DATE AS OF CHANGE: 20180122 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HURLY STEPHEN A CENTRAL INDEX KEY: 0001130637 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 18540003 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS STREET 2: 215 FIRST ST. #400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_151665554836712.xml FORM 4 X0306 4 2018-01-18 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001130637 HURLY STEPHEN A C/O ELEVEN BIOTHERAPEUTICS, INC. 245 FIRST STREET, SUITE 1800 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 1.59 2018-01-18 4 A 0 80430 0 A 2018-01-18 2027-10-03 Common Stock 80430.0 80430 D On October 4, 2017, the reporting person was granted an option to purchase 420,000 shares of common stock. This option vests in installments based on the achievement of certain strategic and clinical milestones. On January 18th, 2018, the Compensation Committee of the Board of Directors of the Company determined that one of these performance milestones was met, resulting in vesting of the option with respect to 80,430 shares. /s/ Stephen A. Hurly 2018-01-22